Corbus Pharmaceuticals Holdings, Inc. financial data

Symbol
CRBP on Nasdaq
Location
Norwood, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 853% % 7.1%
Debt-to-equity 14% % -15%
Return On Equity -66% % -111%
Return On Assets -58% % -115%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17,736,464 shares 45%
Common Stock, Shares, Outstanding 17,611,511 shares 45%
Entity Public Float $67,800,000 USD -84%
Common Stock, Value, Issued $2,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 13,317,116 shares 22%
Weighted Average Number of Shares Outstanding, Diluted 13,317,116 shares 22%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $70,095,000 USD 118%
General and Administrative Expense $15,215,000 USD -7.8%
Operating Income (Loss) $85,310,000 USD -75%
Nonoperating Income (Expense) $6,773,000 USD -20%
Net Income (Loss) Attributable to Parent $78,537,000 USD -95%
Earnings Per Share, Basic -5.9 USD/shares -60%
Earnings Per Share, Diluted -5.9 USD/shares -60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $28,492,000 USD 66%
Assets, Current $166,954,000 USD 9.1%
Property, Plant and Equipment, Net $159,000 USD -59%
Operating Lease, Right-of-Use Asset $1,082,000 USD -49%
Other Assets, Noncurrent $0 USD -100%
Assets $168,195,000 USD 7.9%
Accounts Payable, Current $2,215,000 USD -54%
Employee-related Liabilities, Current $2,859,000 USD 26%
Accrued Liabilities, Current $16,844,000 USD 210%
Liabilities, Current $20,692,000 USD 75%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $20,692,000 USD 54%
Accumulated Other Comprehensive Income (Loss), Net of Tax $53,000 USD -251%
Retained Earnings (Accumulated Deficit) $555,430,000 USD -16%
Stockholders' Equity Attributable to Parent $147,503,000 USD 3.6%
Liabilities and Equity $168,195,000 USD 7.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $16,421,000 USD -106%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $18,123,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 17,611,511 shares 45%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,702,000 USD 349%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29,162,000 USD 63%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $127,606,000 USD 21%
Deferred Tax Assets, Gross $127,606,000 USD 21%
Operating Lease, Liability $1,633,000 USD -50%
Depreciation $200,000 USD -67%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $78,625,000 USD -96%
Lessee, Operating Lease, Liability, to be Paid $1,688,000 USD -52%
Property, Plant and Equipment, Gross $4,465,000 USD 0.16%
Operating Lease, Liability, Current $1,633,000 USD 1.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,688,000 USD -6%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,688,000 USD -6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $55,000 USD -77%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,688,000 USD -6%
Deferred Tax Assets, Operating Loss Carryforwards $78,535,000 USD 25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $702,984,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $6,288,000 USD 2.3%
Interest Expense $652,000 USD -35%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%